Gender and Age
Item
male 18 years and older
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
histologically confirmed prostate adenocarcinoma (pT staged)
Item
histologically confirmed prostate adenocarcinoma stage pathological tumor-2 (pT2)
boolean
C0679557 (UMLS CUI [1,1])
C0007112 (UMLS CUI [1,2])
C0443276 (UMLS CUI [2,1])
C0475455 (UMLS CUI [2,2])
post radical primary prostatectomy
Item
post radical primary prostatectomy
boolean
C0231290 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C0194810 (UMLS CUI [1,3])
completion of DCVAC/PCa arm in prior study, without objective progression of the disease
Item
completion of DCVAC/PCa arm in study SP003, without objective progression of the disease
boolean
C2348568 (UMLS CUI [1,1])
C3897817 (UMLS CUI [1,2])
C0332197 (UMLS CUI [2,1])
C0242656 (UMLS CUI [2,2])
prior androgen deprivation therapy for prostate cancer
Item
prior androgen deprivation therapy for prostate cancer
boolean
C0205156 (UMLS CUI [1,1])
C0279492 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
peripheral neuropathy (Common Toxicity Criteria)
Item
peripheral neuropathy of common toxicity criteria (CTC) grade 2 or greater
boolean
C0031117 (UMLS CUI [1])
C1516728 (UMLS CUI [2,1])
C0441800 (UMLS CUI [2,2])
other uncontrolled intercurrent illness
Item
other uncontrolled intercurrent illness
boolean
C0205318 (UMLS CUI [1,1])
C3640977 (UMLS CUI [1,2])
treatment with immunotherapy against PCa
Item
treatment with immunotherapy against PCa
boolean
C0021083 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
clinically significant cardiovascular disease
Item
clinically significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
active autoimmune disease requiring treatment
Item
active autoimmune disease requiring treatment
boolean
C0205177 (UMLS CUI [1,1])
C0004364 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])